Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Validation and quantification of major biomarkers in ‘Mahasudarshan Churna’- an ayurvedic polyherbal formulation through high-performance thin-layer chromatography

Fig. 1

Densitogram obtained from Standard- ursolic and oleanolic acid (1 a) using n-hexane: ethyl acetate: acetone (16.4: 3.6: 0.2 v/v) mobile phase; formulation samples containing ursolic and oleanolic acid (1 b); Standard-mangiferin (2 a); formulation samples containing mangiferin (2 b) using ethyl acetate: glacial acetic acid: formic acid: water (20: 2.2: 2.2: 5.2 v/v) mobile phase; Standard- gallic acid (3 a); Standard- quercetin (3 b); Standard- curcumin (3 c) using toluene: ethyl acetate: formic acid (13.5: 9: 0.6 v/v) mobile phase; and formulation samples contains gallic acid, quercetin and curcumin (3 d). HPTLC fingerprinting (1c; 2c; 3e) showing track 1; 2; 3–5: STANDARD-oleanolic and ursolic acid; mangiferin; gallic acid; quercetin and curcumin respectively where tracks M1, M2 and M3 signifying marker compounds in three different commercial formulations (MC1, MC2 and MC3)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us